20 research outputs found

    Functional analysis of mSix1-8 in chick.

    No full text
    <p>(A) Schematic diagram of mutation analysis of mSix1-8 enhancer in the DRG. Various mSix1-8-EGFP reporters were co-electroporated into the left side of the neural tube with the control wild-type reporter (mSix1-8wt-mRFP1) at HH14, and fluorescence intensities of EGFP and mRFP1 in the DRG were examined at 48 h.p.e. (B) Results of mutation analysis of mSix1-8 in the DRG. mSix1-8wt-mRFP1 (red) was co-electroporated with various EGFP constructs (green): mSix1-8wt (Ba, Ba'), mSix1-8NR1-4m (Bb, Bb'), mSix1-8TCF/LEFm2 (Bc, Bc'), mSix1-8SMADm (Bd, Bd'), mSix1-8bHLH12m (Be, Be') and mSix1-8POU12m (Bf, Bf'). Numbers in brackets correspond to the bar numbers (1–9) in C. The wild-type reporter (Ba-Bf, Ba') marked the DRG (drg) and weakly the neural tube (nt), while all mutations reduced EGFP levels (Bb'-Bf'). mSix1-8NR1-4m almost completely abolished mSix1-8 enhancer activity (Bb, Bb'). The image is a dorsal view of the trunk region, and anterior is to the left. (C) Quantification of the effect of various mutations on Six1-8 enhancer activity in the DRG. The relative EGFP/mRFP1 levels were calculated for each embryo by measuring five DRG, and are shown relative to the value obtained from the wild-type reporter (100%). Data are mean±SD. The relative EGFP level detected in the DRG that received reporters with various mutations was significantly lower (*<i>p</i><0.001) than that of embryos received wild-type reporter. 1: wild-type (n = 7), 2: NR1m (n = 5), 3: NR2m (n = 6), 4: NR1-4m (n = 8), 5: TCF/LEFm2 (n = 6), 6: SMADm (n = 8), 7: bHLH12m (n = 6), 8: POU12m (n = 6), 9: YYm (n = 7). (D) Schematic diagram of mutation analysis of mSix1-8 enhancer in cranial ganglia. Three mSix1-8-EGFP reporters were co-electroporated into the entire epiblast with the control wild-type reporter (mSix1-8wt-mRFP1) at HH4-5, and the fluorescence intensities of EGFP and mRFP1 in the head region were examined at 48 h.p.e. (E) Mutation analysis of mSix1-8 in cranial ganglia. mSix1-8wt-mRFP1 (red) was co-electroporated with various EGFP constructs (green): mSix1-8wt (Ea, Ea', Ea''), mSix1-8NR1-4m (Eb, Eb', Eb'') and mSix1-8TCF/LEFm2 (Ec, Ec', Ec''). Numbers in brackets correspond to the bar numbers in F. The wild-type reporter (Ea-Ec, Ea') marked the trigeminal ganglion (V), geniculate (VII)/vestibuloacoustic (VIII) ganglion complex (VII/VIII) and weakly the otic vesicle (ov), while the two mutations reduced EGFP levels (Eb'-Ec'). mSix1-8NR1-4m almost completely abolished mSix1-8 enhancer activity (Eb, Eb'). mSix1-8wt shows weak enhancer activity in the posterior optic cup (opc, Eb and Ec). Each image is a lateral view of the left side of the head/neck. Anterior is to the left and dorsal is to the top. (F) Quantification of the effect of the two mutations on mSix1-8 enhancer activity in the trigeminal ganglion. The relative EGFP/mRFP1 levels were calculated for each embryo by measuring trigeminal ganglia of both sides, and are shown relative to the value obtained from the wild-type reporter (100%). Data are mean±SD. The relative EGFP level detected in trigeminal ganglia that received reporters with the two mutations was significantly lower (*<i>p</i><0.001) than that of embryos received wild-type reporter. 1: wild-type (n = 5), 2: NR1-4m (n = 8), 3: TCF/LEFm2 (n = 7). drg: dorsal root ganglia, nt: neural tube, opc: optic cup, ov: otic vesicle, V: trigeminal ganglion, VII/VIII: VII/VIII ganglion complex. Scale bars: 0.5 mm.</p

    Pattern and specificity of mSix1-8-NLSCre-mediated recombination in embryos.

    No full text
    <p>(A) The structure of a transgene used to generate the mSix1-8-NLSCre transgenic mouse line. mSix1-8 (538 bp) is placed upstream of the tkintron (the HSV thymidine kinase gene promoter and chimeric intron) to drive the expression of NLSCre. The polyA signal is from SV40. The entire expression unit is flanked by two tandem copies of the core region of the HS4 insulator (ins). The positions of the genotyping PCR primers (arrowheads) and the size of the PCR product (406 bp) are shown. Selected restriction sites are also indicated. (B-H) Localization of ß-Gal-positive cells in mSix1-8-NLSCre/R26R-LacZ double transgenic embryos. At E9.0 (Ba), the earliest sign of the appearance of ß-Gal-positive cells was detected in the otic pit region (white square bracket). A close-up view (Bb) shows signals in three scattered cells (black arrowheads) in the otic pit. A section through the posterior part of the otic pit confirmed the presence of ß-Gal-positive cells in the pits of both sides (Bc). At E9.5 (Ca), ß-Gal-positive cells were noted in the developing trigeminal ganglion (black square bracket) and olfactory placode (yellow square bracket) in addition to the otic pit (white square bracket). A close-up view (Cb) shows signals in scattered cells in and around the olfactory placode (white arrowheads). At E9.75 (Da), signals were detected in the developing geniculate ganglion. In a close-up view (Db) showed signals in the ventral portion of the otic vesicle (black arrow). At E10.5 (Ea), clear signals were detected in all the cranial sensory ganglia (V, VII, VIII, IX and X), cells in and around the olfactory epithelium (Eb, a close-up view) and in the DRG. At E11.0 (F), the intensity of the signals in the sensory organs became stronger. Signals were also found in the mesenchyme of forelimb bud (Ea, F-H), hindlimb bud (F-H), branchial arches (Ea, Eb, F-H), and the maxillary process (F-H). In all panels of whole mount embryos, anterior is to the left, dorsal is to the top, and all panels are lateral views. In the transverse section shown in Bc, dorsal is to the top. ba: branchial arches, drg: dorsal root ganglia, fb: forebrain, fl: forelimb bud, hb: hindbrain, hl: hindlimb bud, mp: maxillary process, oe: olfactory epithelium, op: olfactory placode, otp: otic pit, ov: otic vesicle, V: trigeminal ganglia, VII: geniculate ganglia, VII/VIII: VII/VIII ganglion complex, IX: petrosal ganglion, X: nodose ganglion. Scale bars: 2 mm (H), 1 mm (Ba, Ca, Da, Ea, F, G), 0.2 mm (Bb), 0.5 mm (Cb, Db, Eb), 0.1 mm (Bc).</p

    PCR primers used to introduce mutations in mSix1-8.

    No full text
    <p>Positions corresponding to the predicted transcription factor binding sites are underlined. Mutated nucleotides are in lower case.</p><p>PCR primers used to introduce mutations in mSix1-8.</p

    mSix1-8-NLSCre induces sensory neuron-specific recombination in mouse embryos.

    No full text
    <p>(A-I) Immunofluorescence analysis of Cre-mediated recombination in mSix1-8-NLSCre/R26R-LacZ double transgenic embryos. Distribution of ß-Gal was examined at E10.5 (A-D, H), E11.5 (E) and E12.5 (F, G). At E10.5, ß-Gal (Aa) co-localized with a neuron marker ISL1/2 (Aa') in the trigeminal ganglion (yellow signals in Aa''), geniculate-vestibuloacoustic ganglion complex (Ba, Ba', Ba''), petrosal ganglion (Ca, Ca', Ca'') and nodose ganglion (Da, Da', Da'') in transverse sections through the cervical area. In contrast, the same sections stained for a glial marker SOX10 showed no overlap of ß-Gal (green)-positive cells with SOX10 (red)-positive cells in all cranial sensory ganglia (Ab, Bb, Cb, Db). At E11.5, ß-Gal (Ea) also co-localized with ISL1/2 (Ea') in the DRG (yellow signals in Ea'') in a transverse section through the trunk region but not with SOX10 on the same section (Eb). In the frontal sections through the OE at E12.5 (F, G), ß-Gal (green)-positive cells were detected not only in the OE (F, G) but also in the vomeronasal organ (G) and in the surrounding mesenchyme along the TUBB3 (red)-positive axons of the olfactory and vomeronasal sensory neurons (white arrowheads). Many ß-Gal-positive cells were also found in the "migratory mass (white square bracket)" comprising placode-derived migratory cells and axons of olfactory sensory neurons located ventral to the forebrain (F). (H) At E10.5, ß-Gal (green)-positive cells were found in the OE (demarcated by white dotted line) and in an aggregate of TUBB3-positive cells (white arrowheads) located next to the OE. (I) Immunofluorescence analysis of Six1-8 enhancer activity in chick. Frontal section through the olfactory pit of a representative chick embryo at 48 h.p.e. EGFP (green) derived from pT2A-BB-mSix1-8-EGFP was detected in the OE and in an aggregate of TUBB3 (red)-positive cells (yellow arrow) located subjacent to the OE, a likely avian homolog of the rodent migratory mass. DAPI was used for nuclear staining (blue, Aa'', Ab, Ba'', Bb, Ca'', Cb, Da'', Db, Ea'', Eb, F-I). In all panels, dorsal is to the top and midline is to the left (A-E, H) or right (F, G, P). drg: dorsal root ganglia, fb: forebrain, mm: migratory mass, oe: olfactory epithelium, ov: otic vesicle, vno: vomeronasal organ, V: trigeminal ganglia, VII: geniculate ganglia, VIII: vestibuloacoustic ganglion, IX: petrosal ganglion, X: nodose ganglion. Scale bars: 0.1 mm (A-I).</p

    Functional analysis of mSix1-8 in mouse.

    No full text
    <p>(A) Mutation analysis of mSix1-8 in mouse. Wild-type (mSix1-8wt-LacZ, Aa) and mutated [(mSix1-8NR1-4m-LacZ, Ab) and (mSix1-8TCF/LEFm2-LacZ, Ac)] transgenes were used for transgenesis and ß-Gal localization was examined at E10.5. Embryos injected with the wild-type transgene showed ß-Gal activity specifically in the trigeminal ganglion, the VII/VIII ganglion complex and epibranchial placode/ganglia (Aa)[<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0136666#pone.0136666.ref017" target="_blank">17</a>]. However, ß-Gal activity was almost completely lost in an embryo carrying NR1-4m mutation, with the exception of a small number of ectopic ß-Gal-positive cells in the cervical area (Ab). In an embryo carrying TCF/LEFm2 mutation, ß-Gal activity was lost in the sensory organs and ganglia, with the exception of ectopic activity in the somites (Ac). drg: dorsal root ganglia, so: somites, V: trigeminal ganglion, VII/VIII: VII/VIII ganglion complex, IX: petrosal ganglion, X: nodose ganglion. Scale bars: 1 mm. (B) Summary of the phenotypes of transgenic mouse embryos. transgenic embryos: the total number of transgenic embryos obtained using each transgene, pattern A: number of embryos with ß-Gal staining pattern in which the signal in the trigeminal ganglion stands out as the major ß-Gal-positive domain (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0136666#pone.0136666.g003" target="_blank">Fig 3Aa</a> represents a typical pattern A staining), pattern B: number of embryos with ß-Gal staining in which signals in the cranial ganglia was reduced while those in the DRG were relatively unaffected, embryos with ectopic expression: number of embryos with an ectopic LacZ staining, embryos without sensory ganglia-expression: number of embryos without a LacZ staining in the sensory ganglia. Parts of the results obtained using the wild-type transgene were reported previously [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0136666#pone.0136666.ref017" target="_blank">17</a>].</p

    A Novel Reporter Rat Strain That Conditionally Expresses the Bright Red Fluorescent Protein tdTomato

    No full text
    <div><p>Despite the strength of the Cre/loxP recombination system in animal models, its application in rats trails that in mice because of the lack of relevant reporter strains. Here, we generated a floxed STOP tdTomato rat that conditionally expresses a red fluorescent protein variant (tdTomato) in the presence of exogenous Cre recombinase. The tdTomato signal vividly visualizes neurons including their projection fibers and spines without any histological enhancement. In addition, a transgenic rat line (FLAME) that ubiquitously expresses tdTomato was successfully established by injecting intracytoplasmic <i>Cre</i> mRNA into fertilized ova. Our rat reporter system will facilitate connectome studies as well as the visualization of the fine structures of genetically identified cells for long periods both <i>in vivo</i> and <i>ex vivo</i>. Furthermore, FLAME is an ideal model for organ transplantation research owing to improved traceability of cells/tissues.</p></div

    Three-dimensional imaging of hippocampal CA1 after tissue clearing.

    No full text
    <p>(A) Three-dimensional reconstruction of the CA1 region of the hippocampus, which was treated with CUBIC reagent 1 for 2 days and imaged under two-photon microscopy. The laminar structure of pyramidal cells was obvious. Axons and dendrites were brightly labeled by tdTomato and easily traced throughout the tissue. (B) X–Y, X–Z, and Y–Z planar sections of the image shown in (A).</p

    <i>In utero</i> electroporation of <i>Cre</i> plasmid in the brains of floxed STOP tdTomato reporter transgenic rats.

    No full text
    <p>(A) tdTomato expression in layer 2/3 of the cerebral cortex (P0, <i>n</i> = 2). The migrating neurons and L2/3 small pyramidal cells were fluorescently labeled with their axonal branches. LV: lateral ventricle. (<b>B</b>) Layer 2/3 neurons: tdTomato fluorescence (i) and Nissl staining (ii).</p

    Specific expression of tdTomato in phox2b-Cre/floxed STOP tdTomato double transgenic rats.

    No full text
    <p>(A) Plain image (i) and tdTomato fluorescence image (ii) from whole embryos (E12.5): the oculomotor (III) and trochlear (IV) motor nuclei in the central nervous system (III and IV), and the three epibranchial sensory/distal ganglia; geniculate VII, petrosal IX, and nodose X ganglia (gVII, gIX, and gX, respectively). Note that the axons of spinal accessory nucleus (arrowhead) and neurons in the ventral neural tubes (arrow) are also fluorescent. (B, C) Brainstem of neonatal rat: tdTomato (i) and anti-Phox2b (ii). nTS, sensory neurons of the nucleus of the solitary tract; dmnX, dorsal motor nucleus of the vagus nerve; nA, nucleus ambiguus; AP, area postrema; VII, facial nucleus; RTN/pFRG, retrotrapezoid nucleus/parafacial respiratory group. (D) Co-localization of tdTomato and Phox2b: from left to right, tdTomato, anti-Phox2b, DAPI, and the merge.</p
    corecore